How much funding has Tenax Therapeutics raised?

Tenax Therapeutics has raised $125.0M in total funding, most recently a Corporate Round.

Who are Tenax Therapeutics's investors?

Tenax Therapeutics's investors include RTW Investments.

When was Tenax Therapeutics founded?

Tenax Therapeutics was founded in 1967.

Where is Tenax Therapeutics headquartered?

Tenax Therapeutics is headquartered in Chapel Hill, North Carolina, United States.

What industry is Tenax Therapeutics in?

Tenax Therapeutics operates in Biotech, Healthcare.

How many employees does Tenax Therapeutics have?

Tenax Therapeutics has 1-10 employees.

Tenax Therapeutics

IPO

Tenax

Public · Chapel Hill, United States · Founded 1967 · $125.0M raised

Biotech

Healthcare

Headquarters: Chapel Hill, North Carolina
Employees: 1–10
Founded: 1967
Business Model: B2B
Website: tenaxthera.com

Total Funding: $125.0M
Last Round: $25.0M Corporate RoundMar 2025
Rounds: 2
Type: Public

About

Tenax Therapeutics is a Phase 3 specialty pharmaceutical company focused on identifying, developing, and commercializing novel therapies for cardiopulmonary diseases including pulmonary arterial hypertension and heart failure. The company leverages clinical insights into pulmonary and cardiovascular disorders to advance its pipeline of treatments for patients with unmet medical needs.

Summary

Tenax Therapeutics is a Biotech company based in Chapel Hill, United States, founded in 1967. It has raised $125.0M in total across 2 rounds, most recently a $25.0M Corporate Round round in Mar 2025. Investors include RTW Investments.